| Patient | Dwight D. Eisenhower |
|---|---|
| Date of birth | 1960-10-14 |
| Identifiers | MRN HR-ET015-SYN; SSN (made up) 000-15-2673 |
| Document date | 2026-10-19 |
| Author | Russell Okonkwo, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Initial annual wellness visit; no new complaints. [S]
Mr. Eisenhower comes for his first annual wellness visit, three weeks after his one-year coronary review, at which ticagrelor was stopped and he continued aspirin alone. He completed the health risk assessment before the visit. He has had no chest pain, breathlessness, palpitations, or further nosebleeds, and has not needed nitroglycerin. He works full time, travels often, walks most days, and plays golf twice a week. He takes his medicines from a weekly organizer and has added no over-the-counter medicines or supplements. He has had no falls. [S]
| Element | Detail |
|---|---|
| Visit | Initial annual wellness visit |
| Cardiac symptoms | None; no nitroglycerin use |
| Safety events | No falls; no further nosebleeds |
| Medicines | Adherent with a weekly organizer; no new over-the-counter medicines or supplements |
| Active conditions | Coronary artery disease after myocardial infarction, hyperlipidemia, and hypertension, all controlled |
| Functional status | Independent in all activities and instrumental activities of daily living; working full time |
Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Very good, and better than a year ago |
| Psychosocial | Married; strong family and work supports; work stress high but manageable; sleeps about seven hours |
| Behavioral | Former heavy cigarette smoker, quit about seven years ago, no relapse; one or two drinks a week; walks most days and plays golf twice a week; Mediterranean-style diet |
| Activities of daily living | Independent in bathing, dressing, eating, toileting, and transfers |
| Instrumental activities of daily living | Manages his own medicines, finances, and travel |
| Home safety | Smoke detectors working; seat belt always; firearms not kept at home |
| Hearing and vision | No hearing concerns; reading glasses; last eye examination more than two years ago |
| Bladder | No urinary symptoms |
| Memory | No concerns from him or his family |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight stable; good energy; no fever |
| Eyes | Negative | No change in vision with reading glasses |
| Ears, nose, mouth, and throat | Negative | No hearing loss or further nosebleeds |
| Cardiovascular | Negative | No chest pain, palpitations, orthopnea, or ankle swelling |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No black stools or reflux |
| Genitourinary | Negative | No hesitancy, nocturia beyond once, or hematuria |
| Musculoskeletal | Negative | No joint pain or falls |
| Integumentary | Negative | No new or changing skin lesions |
| Neurological | Negative | No weakness, numbness, speech change, or memory change |
| Psychiatric | Negative | Mood good; PHQ-2 score 0 |
| Hematologic | Negative | Less bruising since ticagrelor stopped |
12 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2025-09-24 | active | S |
| Ticagrelor 90 mg oral tablet, one tablet by mouth twice daily | One tablet by mouth twice daily | Oral route | 2025-09-24 to 2026-09-28 | completed | S |
| Atorvastatin 80 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2025-09-24 | active | S |
| Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2025-09-25 | active | S |
| Lisinopril 5 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2025-09-26 to 2026-01-12 | completed | S |
| Lisinopril 10 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-01-12 | active | S |
| Ezetimibe 10 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-01-12 | active | S |
| Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if pain is not better 5 minutes after the first tablet | One tablet under the tongue every 5 minutes as needed for chest pain, up to 3 doses | Sublingual route | 2025-09-24 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-10-19 | Body height | 178 | cm | S |
| 2026-10-19 | Body weight | 77.2 | kg | S |
| 2026-10-19 | Body mass index (BMI) [Ratio] | 24.4 | kg/m2 | S |
| 2026-10-19 | Systolic blood pressure | 126 | mm[Hg] | S |
| 2026-10-19 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-10-19 | Heart rate | 60 | /min | S |
| 2026-10-19 | Respiratory rate | 14 | /min | S |
| 2026-10-19 | Body temperature | 36.6 | Cel | S |
| 2026-10-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-10-19 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2026-10-19 | Total score [Mini-Cog] | 5 | {score} | S | ||
| 2026-10-19 | Total score [AUDIT-C] | 1 | {score} | S |
Vital signs recorded on 2026-10-19; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well-appearing; weight 77.2 kg, stable |
| Eyes | Pupils equal and reactive; near vision 20/25 with reading glasses |
| Ears | Canals clear; whispered-voice test passed on both sides |
| Neck | No carotid bruits; jugular venous pressure not raised |
| Cardiovascular | Regular rhythm; no murmur or gallop; pedal pulses present; no edema |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Soft and non-tender; no pulsatile mass or aortic bruit |
| Musculoskeletal | Timed Up and Go 8 seconds with a steady gait |
| Neurological | Oriented; Mini-Cog 5 of 5 (recall 3 of 3, clock normal) |
| Psychiatric | Euthymic, direct, and engaged |
| Skin | Sun damage on the scalp and forearms; no suspicious lesions |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Anterior ST-elevation myocardial infarction about four months before intake, treated with a drug-eluting stent to the left anterior descending artery; synthetic modern episode linked to the documented 1955 anterolateral infarction | active | confirmed | I25.2 | S — Synthetic modern diagnosis; the 1955 infarction remains D in the history. |
| Coronary artery disease, single-vessel, after stenting; no angina | active | confirmed | I25.10 | S — Synthetic diagnosis supporting secondary prevention. |
| Hyperlipidemia, on high-intensity statin | active | confirmed | E78.5 | S — Synthetic diagnosis; no cholesterol value from his lifetime is used. |
| Essential hypertension | active | confirmed | I10 | S — Synthetic diagnosis; no blood pressure from his lifetime is used. |
| Former heavy cigarette smoker, quit about seven years before intake | active | confirmed | Z87.891 | S — Synthetic coded history echoing the documented heavy smoking and quitting around 1949. |
| Anterior epistaxis, right side, on dual antiplatelet therapy; controlled with silver nitrate cautery | resolved | confirmed | R04.0 | S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Influenza vaccine, 2026-2027 | Completed today | High-dose vaccine given today |
| COVID-19 vaccine, 2026-2027 | Due | Recommended with coronary disease; he plans to get it at his pharmacy |
| Pneumococcal vaccine | Up to date | PCV20 given in January; no further doses needed |
| RSV vaccine | Up to date | Single dose given at the one-year review three weeks ago |
| Recombinant zoster vaccine | Up to date | Two-dose series completed about three and a half years ago |
| Tetanus booster | Up to date | Tdap about seven years ago; next due in about three years |
| Abdominal aortic aneurysm screening | Ordered | One-time ultrasound for a man aged 65 to 75 who has ever smoked |
| Lung cancer screening | Ordered | Age 66, well over 20 pack-years, quit about seven years ago. After shared decision-making about benefits, false positives, and radiation, he chose yearly low-dose CT; first scan ordered |
| Colorectal cancer screening | Up to date | Normal colonoscopy five years ago; next due in five years |
| Prostate cancer screening | Declined | Shared decision-making about the small benefit and the risks of overdiagnosis; he chose not to have PSA testing |
| Hepatitis C screening | Up to date | One-time screen negative in the past |
| Cholesterol and diabetes screening | Up to date | LDL cholesterol 49 mg/dL three weeks ago; HbA1c 5.6% in January, due again in January |
| Depression screening | Completed today | PHQ-2 score 0 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 1 |
| Cognitive assessment | Completed today | Mini-Cog 5 of 5 |
| Falls and functional assessment | Completed today | No falls; Timed Up and Go 8 seconds |
| Tobacco use | Completed today | Abstinent; relapse-prevention advice given |
| Eye examination | Due | More than two years since his last examination; he will book with his optometrist |
Immunizations given today: High-dose influenza vaccine, 2026-2027 season [S]
Guideline basis: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); Medicare Wellness Visits (Medicare Learning Network) (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026)
Follow-up: Abdominal aortic ultrasound and low-dose chest CT ordered. Coronary review with laboratory tests in about six months. Subsequent annual wellness visit in one year. [S]
Voluntary advance care planning discussion of about 20 minutes, with his consent. He has named a health care agent and completed a written health care directive; a copy is now in the chart. He wants full treatment, including coronary procedures and intensive care, for any condition from which he could return to an active life. He would not want prolonged life support if he were unlikely to recover the ability to think and communicate. He will review these wishes with his agent. [S]